Cargando…
Transforming Growth Factor-β1 and Incident Type 2 Diabetes: Results from the MONICA/KORA case-cohort study, 1984–2002
OBJECTIVE: Subclinical inflammation leads to insulin resistance and β-cell dysfunction. This study aimed to assess whether levels of circulating transforming growth factor-β1 (TGF-β1)—a central, mainly immunosuppressive, and anti-inflammatory cytokine—were associated with incident type 2 diabetes. R...
Autores principales: | Herder, Christian, Zierer, Astrid, Koenig, Wolfgang, Roden, Michael, Meisinger, Christa, Thorand, Barbara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2752926/ https://www.ncbi.nlm.nih.gov/pubmed/19592635 http://dx.doi.org/10.2337/dc09-0476 |
Ejemplares similares
-
Biomarker-defined pathways for incident type 2 diabetes and coronary heart disease—a comparison in the MONICA/KORA study
por: Huth, Cornelia, et al.
Publicado: (2020) -
Effect of Serum 25-Hydroxyvitamin D on Risk for Type 2 Diabetes May Be Partially Mediated by Subclinical Inflammation: Results from the MONICA/KORA Augsburg study
por: Thorand, Barbara, et al.
Publicado: (2011) -
Immunological and Cardiometabolic Risk Factors in the Prediction of Type 2 Diabetes and Coronary Events: MONICA/KORA Augsburg Case-Cohort Study
por: Herder, Christian, et al.
Publicado: (2011) -
A Panel of 6 Biomarkers Significantly Improves the Prediction of Type 2 Diabetes in the MONICA/KORA Study Population
por: Thorand, Barbara, et al.
Publicado: (2020) -
Subclinical Inflammation and Diabetic Polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany)
por: Herder, Christian, et al.
Publicado: (2009)